Lamia Aïssi-Rothé

Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: Comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression

Véronique Decot, Laure Voillard, Véronique Latger‐Cannard et al. · Experimental Hematology · 2010 · 69 citations

Life Sciences, Immunology, Oncology +16

The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation

Maud D’Aveni, Lamia Aïssi-Rothé, Véronique Venard et al. · Transplant Immunology · 2011 · 31 citations

Life Sciences, Hematology, Immunology +15

Rapid Generation of Full Clinical-Grade Human Antiadenovirus Cytotoxic T Cells for Adoptive Immunotherapy

Lamia Aïssi-Rothé, Véronique Decot, Véronique Venard et al. · Journal of Immunotherapy · 2010 · 29 citations

Life Sciences, Immunology, Infectious Diseases +13

Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy

Yingying Wang, Lamia Aïssi-Rothé, J.-M. Virion et al. · Cytotherapy · 2013 · 10 citations

Life Sciences, Immunology, Oncology +12